Stay updated on Lorlatinib Combos in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lorlatinib Combos in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology. The study record details remain unchanged.
    Difference
    0.8%
    Check dated 2026-10-25T03:01:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T02:40:05.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T04:38:13.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The record history adds a new site revision entry, 'Revision: v3.7.0', replacing the previous 'Revision: v3.6.6' in the version log.
    Difference
    0.1%
    Check dated 2026-09-20T01:42:37.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.6, was added to the study record history, indicating the page was updated to the latest release version. This reflects a maintenance update to the record rather than changes to trial content or eligibility.
    Difference
    0.1%
    Check dated 2026-08-29T19:48:32.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The revision label in the study history updates from v3.6.4 to v3.6.5. This reflects a newer version of the page metadata rather than any study data change.
    Difference
    0.1%
    Check dated 2026-08-08T17:09:54.000Z thumbnail image

Stay in the know with updates to Lorlatinib Combos in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.